A new medical isotope project at Los Alamos National Laboratory in New Mexico, has shown promise for producing major quantities of a new cancer-treatment agent, actinium 225 (Ac-225).
The FDA has approved Amyvid, a radioactive diagnostic agent from Eli Lilly and Avid Radiopharmaceuticals that is indicated for brain imaging of beta-amyloid plaques in patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline.
Standardized uptake value of regional lymph nodes on PET/CT may provide a threshold to differentiate benign and malignant lymph nodes in patients with inflammatory breast cancer, according to a study published in the May issue of Academic Radiology.
GE Healthcare and Dyax have signed a licensing agreement for the development and commercialization of peptides binding to c-Met, which provides upfront, milestone and royalty payments to Dyax. The license includes application of the peptides in PET, SPECT and optical imaging.
Canada lags behind other developed nations in its use of PET scanning, and “a nationally coordinated strategy to take up this technology and standardize its use could bring Canada back to the forefront of global cancer care,” according to a report commissioned by TRIUMF and Advanced Applied Physics Solutions.
Zecotek Imaging Systems, a subsidiary of Zecotek Photonics, has started legal action in U.S. Federal District Court in Los Angeles against defendants Saint-Gobain and Philips Healthcare for infringement of Zecotek’s U.S. Patent Number 7,132,060, which covers the substances and chemical formulations used to grow lutetium fine silicate scintillation crystals, typically used in imaging devices.
A team of University of California, Los Angeles scientists who developed a chemical marker to help assess the neurological changes associated with cognitive impairment and dementia have found the brain-imaging tool effectively tracked and predicted cognitive decline over a two-year period, according to a study published in the February issue of
Archives of Neurology.
Capital Health, a hospital network based in New Jersey, has inked a contract with GE Healthcare to install GE's Discovery NM 750b at Capital Health Medical Center - Hopewell in Pennington, N.J.
18F-flutemetamol PET imaging demonstrates strong concordance with histopathology irrespective of timing and sequence of exams in prospective and retrospective settings, and shows promise as a valuable tool to study and possibly facilitate diagnosis of Alzheimer’s disease, both in patients with suspected normal pressure hydrocephalus, and among the wider population, according to a pooled analysis of four studies presented at the 2012 Human Amyloid Imaging (HAI) conference in Miami, Fla.
Bioscan, a developer of preclinical imaging systems, has established a subsidiary in Dijon, France, Bioscan Molecular Imaging France.
Two healthcare organizations in Grenoble, France, are using LabLogic’s Laura radio-chromatography system and instrumentation.
Awards |
Wednesday, December 14
The National Cancer Institute (NCI) has named Huntsman Cancer Institute at the University of Utah in Salt Lake City as a Center for Quantitative Imaging Excellence for its research in cancer screening, treatment and follow-up care, specifically with modalities such as mammography, PET, CT and MRI.
The University of South Florida (USF) has opened the Center for Memory C.A.R.E. (Clinical Assessment, Research and Education), on the second floor of the six-story USF Health Byrd Alzheimer’s Institute, to support patients and their caregivers.
Molecular imaging company Positron has signed a letter of intent to buy Manhattan Isotope Technology (MIT), a strontium-82 (SR-82) product specialist, for an undisclosed amount.
Radiologists’ recommendations for follow-up imaging generated 5.3 percent of chest and abdominal CT, brain and lumbar spine MRI and body PET exams, with pulmonary nodule evaluation identified as the most common cause for follow-up imaging, according to a study published online Nov. 15 in
Radiology.
PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, has entered into a commercial agreement with Eli Lilly that grants Siemens PETNET the right to manufacture and distribute Lilly’s molecular imaging agent that is currently under review by the FDA for PET imaging.
ImaginAb has been awarded $2.3 million in funding from the National Cancer Institute's (NCI) Small Business Innovation Research program to help further develop diagnostic imaging agents for PET.
Bracco Diagnostics has sent its customers an update regarding its voluntary recall of the CardioGen-82 rubidium generator. The company indicated that user error, a higher than expected strontium breakthrough, or a combination of both factors likely accounted for the triggering of gamma ray emission sensors by two patients crossing the U.S. border in July.
The Centre for Addiction and Mental Health (CAMH) in Toronto will open the doors to its new Research Imaging Centre, where PET, MRI and genetic imaging will be focused on the study of addictions and mental illness.
The National Institute of Cancer, a Mexican oncologic center, is the first in the country to offer positron emission mammography (PEM), which is a breast application of Naviscan's PET scanner that shows the location as well as the metabolic phase of a lesion.
